Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
Launched by FRED HUTCHINSON CANCER CENTER · Aug 12, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new mobile app called Planning Advance Care Together (PACT) to help people with cancer have important conversations about their future healthcare wishes. The app aims to make it easier for patients to talk about what kind of care they would want if they were unable to speak for themselves. By involving family and friends in this planning process, the PACT app could improve how patients prepare for their care needs.
To participate, patients need to have advanced cancer and be 18 years or older. They must also have access to a mobile device with internet, be able to provide informed consent, and identify a supportive family member or friend to join them in the study. Those who are interested should know that the trial is currently recruiting participants, and the study is designed to help both patients and their support persons feel more comfortable discussing these important topics with their healthcare providers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • PATIENT: Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic cancer and/or disease progression following at least first line systemic therapy.
- • PATIENT: Access to a mobile device; the principal investigator (PI) will ensure that those who have access to a mobile device have access to a mobile device with internet access to ensure they can complete study procedures.
- • PATIENT: The ability to provide informed consent.
- • PATIENT: Identification and enrollment of a loved support person.
- • PATIENT: 18 years of age or older.
- • SUPPORT PERSON: The person (family member or friend) whom the patient indicates being a support person.
- • SUPPORT PERSON: English speaking.
- • SUPPORT PERSON: 18 years of age or older and able to provide informed consent.
- • PROVIDER: Current clinical practice and/or research with advanced cancer patients.
- • PROVIDER: A history of 3+ years working with advanced cancer patients.
- • PROVIDER: 18 years of age or older. Providers across disciplines (e.g., social work, oncology) will be enrolled.
- Exclusion Criteria:
- • PATIENT: Not fluent in English.
- • PATIENT: Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of \>= 6) to be delivered by trained study research staff during screening.
- • PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer).
- • PATIENT: Currently receiving hospice at the time of enrollment.
- • PATIENT: Children and young adults under age 18.
- • PATIENT: Resides outside of the United States.
- • SUPPORT PERSON AND PROVIDERS: Resides outside of the United States.
About Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center is a leading nonprofit research institution dedicated to the pursuit of innovative cancer treatments and prevention strategies. Established in Seattle, Washington, the center is renowned for its pioneering work in hematopoietic cell transplantation and its commitment to advancing cancer research through collaborative clinical trials. By integrating cutting-edge science with compassionate patient care, Fred Hutchinson Cancer Center aims to improve outcomes for patients while fostering a multidisciplinary approach to tackling complex cancer challenges. With a strong emphasis on translating research findings into clinical applications, the center is at the forefront of developing novel therapies that offer hope to patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
New York, New York, United States
Seattle, Washington, United States
Manhasset, New York, United States
Patients applied
Trial Officials
Megan J Shen, PhD
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials